NCT06728826Recruiting
Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy
Pericardiotomy for Prevention of Postoperative Atrial Fibrillation After Cardiac Surgery in China
Source: ClinicalTrials.gov · Last updated 14 Jul 2026
Brief summary (registry, in English)
PRINCE-CH is a multicentre, randomized controlled trial which evaluates the effectiveness and safety of posterior pericardiotomy in preventing POAF after cardiac surgery in Chinese population.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 650 (estimated)
- First submitted
- 8 Dec 2024
- Start date
- 1 Dec 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Changhai Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT06728826
What you commit to
- Study type: Interventional
- Planned participants: 650
- From 1 Dec 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Disease of the left pleura or previous left thoracotomy
Other illness
- History of atrial fibrillation or flutter
- Reoperations/minimally invasive cardiac surgery/emergent presentation
Other
- Need for hypothermic circulatory arrest
- Chest deformity
- Unlikely to participate in follow-up assessments
Who the study is looking for
- Patients older than or equal to 18 years of age
- Requiring surgical intervention on proximal aorta, cardiac valves, and/or coronary arteries
- Able to provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Changhai Hospital Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.